Estimation of overall survival in an 'illness-death' model with application to the vertical transmission of HIV-1

Statistics in Medicine

Volumn 29, Issue 19, 2010, Pages 2045-2054

  Frydman, Halina ^a   Szarek, Michael ^b  

^a NEW YORK UNIVERSITY   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

HIV; Illness death model; Interval censoring; Nonparametric maximum likelihood estimation; Self consistency; Unknown status of intermediate transition

Indexed keywords

ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; DEATH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAXIMUM LIKELIHOOD METHOD; NONHUMAN; OVERALL SURVIVAL; PATIENT COUNSELING; PUERPERIUM; STATISTICAL MODEL; VENOUS BLOOD; VERTICAL TRANSMISSION;

BOTTLE FEEDING; BREAST FEEDING; COUNSELING; DISEASE-FREE SURVIVAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LIKELIHOOD FUNCTIONS; MARKOV CHAINS; MODELS, STATISTICAL; PROBABILITY; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC;

EID: 77955742412     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3949     Document Type: Article

References (24)

1. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New England Journal of Medicine 2004; 350:2343-2351. (Pubitemid 38702845)
2. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine 2006; 354:567-578.
3. Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. New England Journal of Medicine 2007; 357:2666-2676.
4. Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW, Wood WC, Davidson NE. Weekly paclitaxel in the adjuvant treatment of breast cancer. New England Journal of Medicine 2008; 358:1663-1671. (Pubitemid 351549913)
5. Singh BN, Connolly SJ, Crijns H, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. New England Journal of Medicine 2007; 357:987-999. (Pubitemid 47367078)
6. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, Kasonde P, Scott N, Vwalika C, Walter J, Bulterys M, Tsai W, Thea DM. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. New England Journal of Medicine 2008; 359:130-141.
7. Martinez E, Arnaiz JA, Podzamczer D, Dalmau D, Ribera E, Domingo P, Knobel HD, Riera M, Pedrol E, Force L, Llibre JM, Segura F, Richart C, Cortes C, Javaloyas M, Aranda M, Cruceta A, de Lazzari E, Gatell JM. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. New England Journal of Medicine 2003; 349:1036-1046.
8. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA. Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine 2008; 359:2233-2244.
9. Frydman H, Szarek M. Nonparametric estimation in a Markov 'iIlness-death' process from interval censored observations with missing intermediate transition status. Biometrics 2009; 65:143-151.
10. Commenges D. Inference for multi-state models from interval-censored data. Statistical Methods in Medical Research 2002; 11:167-182.
11. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, Ndinya-Achola J, Bwayo J, Onyango FE, Hughes J, Kreiss J. Effect of beastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial of breastfeeding and formula feeding. Journal of the American Medical Association 2000; 283:1167-1174.
12. Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, Mwatha A, Ndinya-Achola J, Bwayo J, Kreiss J. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women. Journal of the American Medical Association 2001; 286:2413-2420.
13. Hughes JP, Richardson BA. Analysis of a randomized trial to prevent vertical transmission of HIV-1. Journal of the American Statistical Association 2000; 95:1032-1043.
14. Frydman H. A nonparametric estimation procedure for a periodically observed three state Markov process with application to aids. Journal of the Royal Statistical Society, Series B 1992; 54:853-866.
15. Frydman H. Nonparametric estimation of a Markov 'illness-death' process from interval-censored observations, with application to diabetes servival data. Biometrika 1995; 82:773-789.
16. Peto R. Experimental survival curves for interval-censored data. Applied Statistics 1973; 22:86-91.
17. Turnbull BW. The empirical distribution function with arbitrary grouped censored and truncated data. Journal of the Royal Statistical Society, Series B 1976; 38:290-295.
18. Banerjee M, Wellner JA. Confidence intervals for current status data. Scandinavian Journal of Statistics 2005; 32:405-424.
19. Politis DN, Romano JP, Wolf M. Subsampling. Springer: New York, 1999.
20. Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Statistics in Medicine 2007; 24:4505-4519.
21. Gupte N, Brookmeyer R, Bollinger R, Gray G. Modeling maternal-infant HIV transmission in the presence of breastfeeding with an imperfect test. Biometrics 2007; 63:1189-1197.
22. Zhang P, Lagakos SW. Analysis of time to a silent event whose occurrence is monitored with error, with application to mother-to-child HIV transmission. Statistics in Medicine 2008; 27:4637-4646.
23. U.S. Food and Drug Administration. Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics. U.S. Food and Drug Administration: Silver Spring, MD, 2007.
24. Tournoud M, Ecochard R. Application of the promotion time cure model with time-changing exposure to the study of HIV/AIDS and other infectious diseases. Statistics in Medicine 2007; 26:1008-1021.